Publications by authors named "Alberto S Pappo"

99Publications

A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies.

Eur J Cancer 2020 Sep 11;137:204-213. Epub 2020 Aug 11.

Departments of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; Departments of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; The Departments of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38103, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2020.06.014DOI Listing
September 2020

An addition to the evolving spectrum of lipofibromatosis and lipofibromatosis-like neural tumor: Molecular findings in an unusual phenotype aid in accurate classification.

Pathol Res Pract 2020 Jun 26;216(6):152942. Epub 2020 Mar 26.

Department of Pathology, University of Colorado, Anschutz Medical Campus, Aurora CO, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2020.152942DOI Listing
June 2020

Optimal dosing of cyclophosphamide in rhabdomyosarcoma: It's complicated.

Cancer 2019 09 7;125(18):3107-3110. Epub 2019 Jun 7.

Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32205DOI Listing
September 2019

Dramatic bone remodeling following larotrectinib administration for bone metastasis in a patient with TRK fusion congenital mesoblastic nephroma.

Pediatr Blood Cancer 2018 10 12;65(10):e27271. Epub 2018 Jun 12.

Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27271DOI Listing
October 2018

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.

N Engl J Med 2018 02;378(8):731-739

From Memorial Sloan Kettering Cancer Center (A. Drilon, J.F.H., R.B., M.L., D.M.H.) and Weill Cornell Medical College (A. Drilon, D.M.H.), New York; University of Texas Southwestern Medical Center-Children's Health, Dallas (T.W.L.); Stanford Cancer Center, Stanford University, Palo Alto (S.K.), Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California (L.M.), and UCLA David Geffen School of Medicine (N.F.), Los Angeles, and Loxo Oncology, South San Francisco (B.B.T., K.E., S.C., N.C.K., M.C.C.) - all in California; Dana-Farber-Boston Children's Cancer and Blood Disorders Center (S.G.D.), Dana-Farber Cancer Institute (G.D.D., M.N.), Ludwig Center at Harvard (G.D.D.), and Massachusetts General Hospital (A.F.F.) - all in Boston; the Finsen Center, Rigshospitalet, Copenhagen (U.N.L.); University of Colorado, Aurora (R.C.D.); St. Jude Children's Research Hospital, Memphis (A.S.P.), and Vanderbilt University, Nashville (J.B.) - both in Tennessee; Cincinnati Children's Hospital Medical Center, Cincinnati (B.T.); University Hospitals of Cleveland Medical Center (A. Dowlati) and Taussig Cancer Institute, Cleveland Clinic (D.P.S.S.), Cleveland; University of Pennsylvania Perelman School of Medicine, Department of Otorhinolaryngology and Head and Neck Surgery, and the Abramson Cancer Center (M.S.B.), and Fox Chase Cancer Center (W.S.E.-D.), Philadelphia; University of Washington-Seattle Cancer Care Alliance (C.B.), Seattle Children's Hospital (E.R.R.), and Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Research Center (D.S. Hawkins), Seattle; University of Texas M.D. Anderson Cancer Center, Houston (F.M.-B., D.S. Hong); Inova Schar Cancer Institute, Falls Church, VA (J.D.); START Madrid, Centro Integral Oncológico Clara Campal, Madrid (V.B.); Nemours Children's Hospital, Orlando (R.N.), and Memorial Cancer Institute-Florida International University, Miami (L.E.R.) - both in Florida; Oregon Health and Science University, Portland (M.T.); and WVU Cancer Institute, West Virginia University, Morgantown (P.C.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1714448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857389PMC
February 2018

Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas.

J Clin Oncol 2018 01 8;36(2):168-179. Epub 2017 Dec 8.

Alberto S. Pappo, St. Jude Children's Research Hospital, Memphis, TN; and Uta Dirksen, University Hospital Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.7402DOI Listing
January 2018

Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.

J Clin Oncol 2017 Dec 23;35(35):3956-3963. Epub 2017 Oct 23.

Emilia Modolo Pinto, Carlos Rodriguez-Galindo, Stanley B. Pounds, Lei Wang, Michael R. Clay, Geoffrey Neale, Catherine G. Lam, Alberto S. Pappo, Gerard P. Zambetti, and Raul C. Ribeiro, St Jude Children's Research Hospital; Elizabeth A.R. Garfinkle, University of Tennessee Health Science Center, Memphis, TN; and Carolyn Fein Levy, Steven and Alexandra Cohen Children's Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.2460DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721229PMC
December 2017

Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697).

J Clin Oncol 2017 Mar 30;35(8):885-892. Epub 2017 Jan 30.

Sanjiv S. Agarwala, Saint Luke's University Hospital, Easton; Uma N. Rao, Ahmad A. Tarhini, Terry L. Evans, and John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA; Sandra J. Lee, and Waiki Yip, Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Gary I. Cohen, Greater Baltimore Medical Center, Baltimore, MD; Douglas S. Reintgen, Lakeland Regional Cancer Center, Lakeland; Vernon K. Sondak, H. Lee Moffitt Cancer Center, Tampa, FL; Joanna M. Brell, MetroHealth Medical Center, Cleveland; William E. Carson, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Mark R. Albertini, University of Wisconsin Hospital, Madison, WI; Michael B. Atkins, Georgetown Medical Center, Washington, DC; Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS; Robert M. Conry, University of Alabama at Birmingham, Birmingham, AL; Jeffrey A. Sosman, Vanderbilt University, Nashville; Alberto S. Pappo, Saint Jude Children's Research Hospital Oncology, Memphis, TN; Lawrence E. Flaherty, Wayne State University/Karmanos Cancer Institute, Detroit, MI; Michael G. Smylie, Cross Cancer Institute, Edmonton, Canada; and Richard F. Kefford, Sydney West Area Health Service, Westmead, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.2951DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455684PMC
March 2017

Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic.

J Clin Oncol 2017 Feb 28;35(5):523-528. Epub 2016 Dec 28.

Christopher B. Weldon and Arin L. Madenci, Boston Children's Hospital; Christopher B. Weldon, Arin L. Madenci, Katherine A. Janeway, and Suzanne George, Harvard Medical School; Christopher B. Weldon, Katherine A. Janeway, and Suzanne George, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Arin L. Madenci, Brigham and Women's Hospital, Boston, MA; Sosipatros A. Boikos, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA; Margaret von Mehren, Fox Chase Cancer Center, Philadelphia, PA; Alberto S. Pappo, St Jude Children's Research Hospital, Memphis, TN; Joshua D. Schiffman and Jennifer Wright, Huntsman Cancer Institute, Salt Lake City, UT; Jonathan C. Trent, Sylvester Comprehensive Cancer Center, Miami, FL; Karel Pacak and Constantine A. Stratakis, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Lee J. Helman, National Cancer Institute, Bethesda, MD; and Michael P. La Quaglia, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.6733DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455315PMC
February 2017

Assessment of Chemotherapy Response in Ewing Sarcoma.

Radiology 2016 11;281(2):647-649

Departments of Diagnostic Imaging * and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2016160903DOI Listing
November 2016

Germline Mutations in Predisposition Genes in Pediatric Cancer.

N Engl J Med 2015 Dec 18;373(24):2336-2346. Epub 2015 Nov 18.

Departments of Computational Biology (J.Z., G.W., M.N.E., D.H., X.M., X.Z., M.R.W., X.C., M.R., A.P., J.B.B., S.W.), Oncology (M.F.W., T.A.G., R.B.M., S.H.-D., R.N., E.Q., A.G., A.S.P., C.-H.P., K.E.N.), and Pathology (T.A.G., M.R.W., S.A.S., D.W.E., C.-H.P., J.R.D.) and the Pediatric Cancer Genome Project (J.Z., M.F.W., G.W., M.N.E., T.A.G., J.E., X.M., D.A.Y., B.V., X.C., R.B.M., S.H.-D., R.N., E.Q., S.A.S., M.R., A.P., J.B.B., S.W., M.S.W., A.G., D.W.E., A.S.P., C.-H.P., K.E.N., J.R.D.), St. Jude Children's Research Hospital, Memphis, TN; and the Department of Genetics and McDonnell Genome Institute, Washington University School of Medicine in St. Louis, St. Louis (L.D., E.R.M., R.K.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1508054DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734119PMC
December 2015

Rare Tumors in Children: Progress Through Collaboration.

J Clin Oncol 2015 Sep 24;33(27):3047-54. Epub 2015 Aug 24.

Alberto S. Pappo and Wayne L. Furman, St Jude Children's Research Hospital, Memphis, TN; Kris A. Schultz, Children's Hospital of Minnesota, Minneapolis, MN; Andrea Ferrari, Instituto Nazionale Tumori, Milano, Italy; Lee Helman, National Cancer Institute Center for Cancer Research, Bethesda, MD; and Mark D. Krailo, Keck School of Medicine, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.3632DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979197PMC
September 2015

Genetic Predisposition to Neonatal Tumors.

Curr Pediatr Rev 2015 ;11(3):164-78

Division of Cancer Predisposition, St. Jude Children's Research Hospital, 262 Danny Thomas Drive, Memphis, TN 38105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1573396311666150714110229DOI Listing
July 2016

Safety and diagnostic accuracy of tumor biopsies in children with cancer.

Cancer 2015 Apr 18;121(7):1098-107. Epub 2014 Dec 18.

Department of Surgery, St Jude Children's Research Hospital, Memphis, Tennessee; Department of Surgery, University of Tennessee Health Science Center, Memphis, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29167DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368446PMC
April 2015

Southwest Oncology Group S0008: a phase III trial of high-dose interferon Alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma--an intergroup study of cancer and leukemia Group B, Children's Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group.

J Clin Oncol 2014 Nov 20;32(33):3771-8. Epub 2014 Oct 20.

Lawrence E. Flaherty, Wayne State University, Detroit; Bruce G. Redman, University of Michigan, Ann Arbor, MI; Megan Othus, James Moon, Southwest Oncology Group Statistical Center; John A. Thompson, Seattle Cancer Care Alliance, Seattle, WA; Michael B. Atkins, Georgetown University Hospital, Washington DC; Ralph J. Tuthill, Cleveland Clinic Foundation, Cleveland, OH; John T. Vetto, Oregon Health & Science University/Knight Cancer Institute, Portland, OR; Frank G. Haluska, Tufts-New England Medical Center, Boston, MA; Alberto S. Pappo, Texas Children's Cancer Center, Houston, TX; Jeffrey A. Sosman, Vanderbilt University School of Medicine Nashville, TN; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA; Vernon K. Sondak, H. Lee Moffitt Cancer Center, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.1590DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226807PMC
November 2014

Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

J Clin Oncol 2014 Nov 29;32(31):3547-52. Epub 2014 Sep 29.

David O. Walterhouse, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL; Alberto S. Pappo, Saint Jude Children's Research Hospital, Memphis, TN; Jane L. Meza, James R. Anderson, University of Nebraska Medical Center College of Public Health, Omaha, NE; John C. Breneman, Children's Hospital Medical Center, Cincinnati; Timothy P. Cripe, Nationwide Children's Hospital, Columbus, OH; Andrea Hayes-Jordan, MD Anderson Cancer Center, Houston, TX; David M. Parham, William H. Meyer, University of Oklahoma School of Medicine, Oklahoma City, OK; Douglas S. Hawkins, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.6787DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209105PMC
November 2014

Ocular manifestations of hypoxia-inducible factor-2α paraganglioma-somatostatinoma-polycythemia syndrome.

Ophthalmology 2014 Nov 8;121(11):2291-3. Epub 2014 Aug 8.

Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ophtha.2014.06.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253312PMC
November 2014

Gastrointestinal stromal tumors, version 2.2014.

J Natl Compr Canc Netw 2014 Jun;12(6):853-62

From Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; The University of Texas MD Anderson Cancer Center; UC San Diego Moores Cancer Center; Moffitt Cancer Center; Memorial Sloan-Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Roswell Park Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; UCSF Helen Diller Family Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; City of Hope Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Duke Cancer Institute; University of Michigan Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/6/853.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0080DOI Listing
June 2014

Pediatric melanoma: the whole (genome) story.

Authors:
Alberto S Pappo

Am Soc Clin Oncol Educ Book 2014 :e432-5

From the Solid Tumor Division, St. Jude Children's Research Hospital, Memphis, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.e432DOI Listing
December 2015

Soft tissue sarcoma, version 2.2014.

J Natl Compr Canc Netw 2014 Apr;12(4):473-83

From 1Fox Chase Cancer Center; 2Huntsman Cancer Institute at the University of Utah; 3The University of Texas MD Anderson Cancer Center; 4UC San Diego Moores Cancer Center; 5Moffitt Cancer Center; 6Memorial Sloan-Kettering Cancer Center; 7Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 8Massachusetts General Hospital Cancer Center; 9Stanford Cancer Institute; 10Dana-Farber/Brigham and Women's Cancer Center; 11University of Alabama at Birmingham Comprehensive Cancer Center; 12Roswell Park Cancer Institute; 13The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 14Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 16UCSF Helen Diller Family Comprehensive Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18City of Hope Comprehensive Cancer Center; 19Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 20Duke Cancer Institute; 21University of Michigan Comprehensive Cancer Center; 22Vanderbilt-Ingram Cancer Center; 23Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and 24National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/4/473.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0053DOI Listing
April 2014

Adolescent and young adult oncology, version 2.2014.

J Natl Compr Canc Netw 2014 Jan;12(1):21-32; quiz 32

From 1Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 2St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 3Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 4City of Hope Comprehensive Cancer Center; 5Vanderbilt-Ingram Cancer Center; 6The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 7Dana-Farber/Brigham and Women's Cancer Center; 8UCSF Helen Diller Family Comprehensive Cancer Center; 9Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 10Massachusetts General Hospital Cancer Center; 11Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 12Roswell Park Cancer Institute; 13Stanford Cancer Institute; 14Memorial Sloan-Kettering Cancer Center; 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 16Moffitt Cancer Center; 17Huntsman Cancer Institute at the University of Utah; 18The University of Texas MD Anderson Cancer Center; 19Fox Chase Cancer Center; 20Duke Cancer Institute; 21University of Alabama at Birmingham Comprehensive Cancer Center; 22University of Michigan Comprehensive Cancer Center; and 23National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0004DOI Listing
January 2014

Adolescent and young adult oncology, version 2.2014.

J Natl Compr Canc Netw 2014 Jan;12(1):21-32; quiz 32

From 1Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 2St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 3Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 4City of Hope Comprehensive Cancer Center; 5Vanderbilt-Ingram Cancer Center; 6The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 7Dana-Farber/Brigham and Women's Cancer Center; 8UCSF Helen Diller Family Comprehensive Cancer Center; 9Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 10Massachusetts General Hospital Cancer Center; 11Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 12Roswell Park Cancer Institute; 13Stanford Cancer Institute; 14Memorial Sloan-Kettering Cancer Center; 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 16Moffitt Cancer Center; 17Huntsman Cancer Institute at the University of Utah; 18The University of Texas MD Anderson Cancer Center; 19Fox Chase Cancer Center; 20Duke Cancer Institute; 21University of Alabama at Birmingham Comprehensive Cancer Center; 22University of Michigan Comprehensive Cancer Center; and 23National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0004DOI Listing
January 2014

Is routine pelvic surveillance imaging necessary in patients with Wilms tumor?

Cancer 2013 Jan 26;119(1):182-8. Epub 2012 Jun 26.

Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27687DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461105PMC
January 2013

Treating rare cancer in children: the importance of evidence.

Authors:
Alberto S Pappo

Am Soc Clin Oncol Educ Book 2012 :586-8

From the Division of Oncology, St. Jude Children's Research Hospital, Memphis, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2012.32.182DOI Listing
April 2016

Special considerations in pediatric gastrointestinal tumors.

J Surg Oncol 2011 Dec;104(8):928-32

St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21868DOI Listing
December 2011

Challenging issues in pediatric oncology.

Nat Rev Clin Oncol 2011 Jun 28;8(9):540-9. Epub 2011 Jun 28.

St. Jude Children's Research Hospital and the University of Tennessee Health Science Center, 262 Danny Thomas Place, Memphis, TN 38105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2011.95DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234106PMC
June 2011

Metastatic squamous cell carcinoma of the oropharynx in a child with a mutation in the Connexin 26 gene.

J Pediatr Hematol Oncol 2011 Jul;33(5):387-9

Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0b013e3181e65c1cDOI Listing
July 2011

Administration of high-dose interleukin-2 in a 2-year-old with metastatic melanoma.

Pediatr Blood Cancer 2009 Dec;53(7):1346-8

Department of Pharmacy, Texas Children's Hospital, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22255DOI Listing
December 2009

Pediatric gastrointestinal stromal tumors.

Hematol Oncol Clin North Am 2009 Feb;23(1):15-34, vii

Department of Pediatrics, Texas Children's Cancer Center, 6621 Fannin Street, CC1510.00, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2008.11.005DOI Listing
February 2009

Reducing irinotecan-associated diarrhea in children.

Pediatr Blood Cancer 2008 Feb;50(2):201-7

Division of Pediatric Hematology/Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21280DOI Listing
February 2008

New drugs for the treatment of metastatic or refractory soft tissue sarcomas in children.

Future Oncol 2006 Oct;2(5):675-85

Hospital for Sick Children, Division of Hematology Oncology, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14796694.2.5.675DOI Listing
October 2006

Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.

J Clin Oncol 2006 Aug;24(24):3844-51

Department of Preventive and Societal Medicine, 984350 Nebraska Medical Center, Omaha, NE 68198-4350, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.3801DOI Listing
August 2006

Childhood nonrhabdomyosarcoma soft tissue sarcomas are not adult-type tumors.

J Clin Oncol 2006 Apr;24(12):1958-9; author reply 1959-60

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.4957DOI Listing
April 2006

Predictors of outcome in children and adolescents with rhabdomyosarcoma of the trunk--the St Jude Children's Research Hospital experience.

J Pediatr Surg 2005 Nov;40(11):1691-5

Department of Pediatric Surgery, KK Women's and Children's Hospital, Singapore 229 899.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpedsurg.2005.07.042DOI Listing
November 2005

Clinical and molecular characteristics of pediatric gastrointestinal stromal tumors (GISTs).

Pediatr Blood Cancer 2005 Jul;45(1):20-4

Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.20377DOI Listing
July 2005

The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma.

Cancer 2005 Feb;103(4):780-7

Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20860DOI Listing
February 2005

Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.

Cancer 2005 Feb;103(4):850-7

Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20823DOI Listing
February 2005

Remote intrapulmonary spread of recurrent respiratory papillomatosis with malignant transformation.

Pediatr Pulmonol 2005 Feb;39(2):185-8

Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ppul.20116
Publisher Site
http://dx.doi.org/10.1002/ppul.20116DOI Listing
February 2005

Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans.

Pediatr Blood Cancer 2005 May;44(5):511-5

Department of Pediatrics, Division Hematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.20249DOI Listing
May 2005

Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Eur J Cancer 2004 Aug;40(12):1878-85

The Division of Hematology/Oncology, Hospital for Sick Children, 555 University Avenue, Toronto, Ont., M5G 1X8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2004.04.005DOI Listing
August 2004

Brain metastases of malignant germ cell tumors in children and adolescents.

Cancer 2004 Aug;101(3):620-6

Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20411DOI Listing
August 2004

Pediatric gastrointestinal stromal tumors and leiomyosarcoma.

Cancer 2004 Jul;101(1):39-50

Department of Hematology-Oncology, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20352DOI Listing
July 2004

Metastatic rhabdomyosarcoma: a retrospective review of patients treated at the hospital for sick children between 1989 and 1999.

J Pediatr Hematol Oncol 2004 Apr;26(4):243-7

Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-200404000-00006DOI Listing
April 2004

Possible allogeneic graft-versus-tumor effect in childhood melanoma.

J Pediatr Hematol Oncol 2003 Dec;25(12):982-6

Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-200312000-00016DOI Listing
December 2003

Orbital inflammatory syndromes with systemic involvement may mimic metastatic disease.

Ophthalmic Plast Reconstr Surg 2003 Jul;19(4):324-7

Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.IOP.0000075022.14333.E9DOI Listing
July 2003

Malignant fibrous histiocytoma and other fibrohistiocytic tumors in pediatric patients: the St. Jude Children's Research Hospital experience.

Cancer 2003 Jun;97(11):2839-47

Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11384DOI Listing
June 2003

Treatment of Ewing sarcoma family of tumors: current status and outlook for the future.

Med Pediatr Oncol 2003 May;40(5):276-87

Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mpo.10240DOI Listing
May 2003

A chemosensitive pediatric extraosseous osteosarcoma: case report and review of the literature.

J Pediatr Hematol Oncol 2003 Jan;25(1):73-7

Departments of Hematology/ Oncology, St. Jude's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105-2794, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-200301000-00015DOI Listing
January 2003

Synovial sarcoma in pediatric patients.

AJR Am J Roentgenol 2002 Sep;179(3):797-801

Department of Diagnostic Imaging, Mail Stop 210, St. Jude Children's Research Hospital, 332 N. Lauderdale St., Memphis, TN 38105-2794, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/ajr.179.3.1790797DOI Listing
September 2002

Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma.

J Clin Oncol 2002 Aug;20(15):3225-35

Department of Hematology-Oncology, St Jude Children's Research Hospital, University of Tennessee College of Medicine, 332 N. Lauderdale Street, Memphis, TN 38105-2794, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.06.066DOI Listing
August 2002

Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposide.

J Pediatr Hematol Oncol 2002 May;24(4):250-5

Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00043426-200205000-00006DOI Listing
May 2002

C-kit expression in pediatric solid tumors: a comparative immunohistochemical study.

Am J Surg Pathol 2002 Apr;26(4):486-92

Department of Pathology, University of Tennessee Medical Center, Memphis, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00000478-200204000-00011DOI Listing
April 2002